Drug Approval Package

Maxalt/Rizatritan Benzoate
Company:  Merck
Application No.:  20864 & 20865
Approval Date: 6/29/1998

• Letter and Label

• Medical Review

• Clinical Review-A

• Clinical Review-B

• Clinical Review-C

• Clinical Review-D

• Clinical Review-E

• Chemistry Review and of Pharmacology Review-A

• Pharmacology-B

• Pharmacology-C

• Pharmacology-D

• Carcinogenicity Test-A

• Carcinogenicity Test-B

• Statistical Review

• Clinical/Pharmacology Review-A

• Clinical/Pharmacology Review-B

• Clinical/Pharmacology Review-C

Date created: March 30, 2001; last update: July 5, 2005

Back to Top    Drugs@FDA

Note: Documents in PDF format require theAdobe Acrobat Reader®.